Compare IMCR & ACCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMCR | ACCV |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2016 | 2026 |
| Metric | IMCR | ACCV |
|---|---|---|
| Price | $26.33 | $9.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $59.30 | $19.00 |
| AVG Volume (30 Days) | 414.0K | ★ 1.5M |
| Earning Date | 11-06-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $249,428,000.00 | N/A |
| Revenue This Year | $9.28 | $103.23 |
| Revenue Next Year | $9.91 | $86.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 43.05 | N/A |
| 52 Week Low | $26.53 | $9.54 |
| 52 Week High | $40.71 | $17.92 |
| Indicator | IMCR | ACCV |
|---|---|---|
| Relative Strength Index (RSI) | 32.57 | 36.09 |
| Support Level | N/A | $9.54 |
| Resistance Level | $31.75 | $15.65 |
| Average True Range (ATR) | 1.46 | 1.84 |
| MACD | -0.46 | -0.07 |
| Stochastic Oscillator | 9.12 | 12.79 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Accelevation Holdings Corp is a vertically integrated infrastructure platform that designs, manufactures and installs power distribution and white space infrastructure products for mission-critical environments. Its offerings comprise Infrastructure Solutions and Power Products, which can be sold separately or combined into integrated systems. Infrastructure Solutions include the SkyBridge modular platform, TechFrame steel structures and conveyance, thermal management products, and installation and maintenance services. Power Products include remote power panels, branch circuit whips, power distribution units, monitoring systems, and upstream distribution products. It derives substantially all of its revenue from offerings sold into the data center industry.